IGM welcomes Christopher Makinson, PhD
New recruit focuses on genetic underpinnings of neurological diseases
Christopher Makinson, PhD is a newly recruited scientist from Stanford University who will be joining Columbia University’s Institute for Genomic Medicine in June of 2020. Educated at Wake Forest University and Emory University, Dr. Makinson completed his postdoctoral training at Stanford University where he became an expert in interrogating neural circuits in epilepsy using state-of-the-art electrical and optical physiology methods. At Columbia, Dr. Makinson uses rodent models and human brain organoids to develop novel avenues for personal/precision medicine. His goal is to increase our understanding of how neural networks give rise to normal and pathological conditions, with an emphasis on elucidating the genetic underpinnings of neurological diseases.